Dysfunctional uterine bleeding laboratory findings

Dysfunctional uterine bleeding Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Dysfunctional uterine bleeding from other Diseases
Epidemiology and Demographics
Risk Factors
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms
Physical Examination
Laboratory Findings
CT
MRI
Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Dysfunctional uterine bleeding laboratory findings On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Dysfunctional uterine bleeding laboratory findings All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Dysfunctional uterine bleeding laboratory findings
CDC on Dysfunctional uterine bleeding laboratory findings
Dysfunctional uterine bleeding laboratory findings in the news
Blogs on Dysfunctional uterine bleeding laboratory findings
Directions to Hospitals Treating Dysfunctional uterine bleeding
Risk calculators and risk factors for Dysfunctional uterine bleeding laboratory findings

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Arooj Naz, Vishnu Vardhan Serla M.B.B.S. [2]

Overview

Women afflicted with dysfunctional uterine bleeding commonly present with CBC changes, particularly changes in red blood cells. Significant laboratory findings may include coagulation profile changes, hormonal levels as well as biomedical markers to detect underlying malignancies.

Laboratory Findings

A pregnancy test should be done to rule out pregnancy related complications leading to dysfunctional uterine bleeding by testing for human chorionic gonadotropin.

CBC

1. RBC: Iron deficiency anemia may be seen; Microcytic, hypochromic anemia with central pallor and target like cells

   

   Iron deficiency anemia; PMID: 28846348

2. WBC: leukocytosis: normal
3. Platelets: changes in platelet count may be seen if coagulopathy is the underlying cause

Coagulation Profile

• Platelets: changes in platelet count may be seen if coagulopathy is the underlying cause
• PT, aPTT and bleeding time vary depending on the underlying coagulopathy
• Normal labs indicate a lack of bleeding disorders as the underlying cause of DUB
• Clotting factor assays

Electrolytes

• No significant changes

Genitourinary Tests

• Pap smear
• Peripheral smear

Hormonal Levels

• TSH
• Prolactin
• Dehydroepiandrosterone-sulfate (DHEA-S)
• Testosterone
• Estradiol
• Follicle stimulating hormone (FSH)
• Luteinizing hormone (LH)
• Serum progesterone

Biomedical Markers

Markers may be helpful in diagnosing an underlying endometrial malignancy. These include:

• Carbohydrate antigen 125 (CA 125)
• Estrogen and progesterone receptor expression
• Presence of mutations (e.g., PTEN, TP53)
• E-cadherin (CDH1)
• Neural cell adhesion molecule L1 (L1CAM)